Compare Definium Therapeutics Inc. Common Shares (DFTX) vs W W Grainger Inc (GWW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs W W Grainger Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while W W Grainger Inc trades at $1,269.13 (market cap $59.51B). The key difference: W W Grainger Inc is far larger — about 12.6× Definium Therapeutics Inc. Common Shares's market cap, and W W Grainger Inc pays a 0.79% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and W W Grainger Inc for 25 Days on average.
| DFTX | GWW | |
|---|---|---|
Market Cap | $4.71B | $59.51B |
Volume | 1,966,636 | 237,326 |
Sector | Health | Industrials |
52-Week High | $48.45 | $1.40K |
52-Week Low | $10.68 | $918.18 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $3.67B | $61.72B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GWW trades at $1,263.51, down 0.94% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth to $18.8B in 2026 and a net income margin of 9.92%. Recent news highlights Grainger's acquisition of technology assets and expansion with a new distribution center, reinforcing its market position.
The outlook is mixed: analyst consensus is a 'Hold' with a $1,310 price target, indicating modest upside. Risks include competitive pressures and economic sensitivity, but solid profitability and institutional buying support long-term value. Investors should weigh steady fundamentals against near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
